Pieris Pharmaceuticals (PIRS) PT Lowered to $6.50 at Oppenheimer
Tweet
Share
E-mailGet Alerts PIRS Hot Sheet
Price: $13.60 --0%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Oppenheimer analyst Hartaj Singh lowered the price target on Pieris Pharmaceuticals (NASDAQ: PIRS) to $6.50 (from $8.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Nomura/Instinet Downgrades Pearl Abyss Corp. (263750:KS) (BRFS) to Neutral
- MYR Group (MYRG) PT Lowered to $422 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
